



Inadequate myocardial performance is a common complication of
severe sepsis. Studies in humans strongly argue against a
decrease in coronary blood flow in the pathogenesis of this sepsis-
inducedcardiac injury. Moreover, regionalmyocardial ischemia may
well be present in sepsis patients with coexistent coronary artery
disease. Nevertheless, the diagnosis of myocardial ischemia
remains difficult in patients with sepsis, since elevation of troponin
in these patients can be the result of a variety of conditions other
than acute myocardial ischemia. The use of the right atrium to
pulmonary artery lactate gradient could perhaps help the clinician
in detecting myocardial ischemia in patients with sepsis.
In this issue, Gutierrez et al. [1] compared simultaneous
measurements of blood lactate concentrations in the right
atrium and pulmonary artery in critically ill patients. They
found decreases in both blood lactate concentrations and
venous blood oxygen saturation in gradients from the right
atrium to the pulmonary artery. These gradients are
presumably produced by mixing right atrial blood with
coronary venous blood, which has lower lactate concentra-
tions and blood oxygen saturation. More interestingly, in this
study, the lactate gradient was inverted in three patients,
suggesting myocardial ischemia, a condition associated with
lactate release by the heart.
Blood lactate levels are typically elevated in hypoperfusion
states when pyruvate cannot enter the Krebs cycle as the
cellular oxygen supply becomes insufficient. The pyruvate is
shunted to lactate through the enzyme lactate dehydro-
genase, producing only two molecules of energy-rich ATP for
every two molecules of pyruvate (from one molecule of
glucose), compared with 38 molecules of ATP for each
glucose molecule through the aerobic mitochondrial process
when sufficient oxygen is present. This causes the lactate to
pyruvate ratio to increase (the normal value is around 10:1).
Once molecular oxygen is again available, assuming that
mitochondrial function is preserved, the excess lactate is
rapidly metabolized back through pyruvate into carbon
dioxide and water via the Krebs cycle. Lactate in the blood is
metabolized mainly by the liver (50%) and kidney (20%). Liver
function and liver blood flow can influence hepatic lactate
clearance. Striated muscles, the heart and the brain can also
metabolize lactate and, in some conditions, this clearance
can be significant.
Traditionally, elevated blood lactate levels in hemodynamically
unstable patients have been interpreted as reflecting acute
circulatory shock. Elevated blood lactate levels have been
correlated with mortality in all types of shock [2,3]. The speed
at which lactate is cleared from the blood through vigorous
resuscitation strongly correlates with ultimate outcome,
including mortality and organ failure. The best chances of
survival occur when resuscitation efforts result in lactate
clearance to normal values within 12 to 24 h [4-6].
Blood lactate concentration represents a global marker of
tissue oxygenation but does not reflect loco-regional tissue
oxygenation. The venoarterial lactate gradient on both sides
of an organ can be used to detect regional hypoxia. De
Backer et al. [7] demonstrated that lung lactate production
occurs in subjects with acute lung injury states but not in
patients with normal lungs, cardiogenic pulmonary edema or
pneumonia. Thus, lung lactate production requires a diffuse
inflammatory process. Other organs can also produce lactate
and experimental studies suggest that the gut can produce
lactate in sepsis, which is probably from anaerobic
metabolism as the portal lactate to pyruvate ratio is
increased. The investigation of splanchnic lactate turnover in
humans is much more complicated as access to the portal
vein is not possible outside the operating room. Since the
liver is usually able to clear this small amount of gut-produced
lactate, splanchnic ischemia may go unsuspected. De Backer
et al. [8] reported that hepatosplanchnic lactate release is
uncommon in patients with severe sepsis and is not related to
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arterial lactate concentrations, abdominal infection or signs of
gut or liver dysoxia.
Inadequate myocardial performance, characterized by left
ventricular systolic depression and diastolic dilatation, is a
common and early complication of septic shock [9,10].
Several factors may contribute to the occurrence of myo-
cardial damage during septic shock. A possible direct cardiac
myocytotoxic effect of bacterial endotoxins or mediators (e.g.
cytokines or reactive oxygen species) induced by the
infectious process and produced by activated leukocytes,
macrophages and endothelial cells [10] should be
considered. Studies in humans [11,12]strongly argue against
a decrease in coronary blood flow in the pathogenesis of this
sepsis-induced cardiac injury. However, a dysfunctional
microcirculation thatproduces regional flow disturbances and
abnormal tissue oxygenation is a hallmark of septic shock,
and may cause relative ischemia in various organs, including
the heart [13,14]. Moreover, regional myocardial ischemia
may well be present in sepsis patients with identifiable
coronary risk factors or coexistent coronary artery disease. In
this context, the diagnosis of myocardial ischemia remains
difficult in sedated and mechanically ventilated patients with
sepsis. Indeed, elevation of troponin can be detected in a
variety of conditions other than acute myocardial ischemia,
especially in critically ill patients with severe sepsis. The use of
the right atrium to pulmonary artery lactate gradient reported
by Gutierrez et al. in this issue [1] could perhaps help the
clinician to detect myocardial ischemia in septic patients.
However, the amplitude of the lactate gradients reported in
this study [1] is close to the measurement error of blood
lactate concentrations provided by many blood gas analyzers.
The present study is a preliminary observation. Further
studies are needed to confirm these results and to study the
usefulness of this lactate gradient in the detection of
myocardial ischemia in critically ill patients.
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